AxoGen Inc. (NASDAQ:AXGN) had its price objective raised by Wedbush from $10.00 to $12.00 in a report released on Monday morning. They currently have an outperform rating on the stock.

Separately, Lake Street Capital cut shares of AxoGen from a buy rating to a hold rating and set a $9.00 price target for the company. in a research report on Thursday, November 3rd.

Shares of AxoGen (NASDAQ:AXGN) traded up 1.23% during trading on Monday, hitting $8.25. The stock had a trading volume of 23,033 shares. The stock’s market cap is $271.41 million. The stock’s 50-day moving average is $8.72 and its 200-day moving average is $7.43. AxoGen has a 12-month low of $4.52 and a 12-month high of $9.88.

AxoGen (NASDAQ:AXGN) last issued its quarterly earnings results on Wednesday, November 2nd. The company reported ($0.08) EPS for the quarter, hitting the consensus estimate of ($0.08). AxoGen had a negative net margin of 33.02% and a negative return on equity of 292.94%. On average, equities research analysts expect that AxoGen will post ($0.38) EPS for the current year.

In other news, Director Amy Mcbride Wendell acquired 13,333 shares of the firm’s stock in a transaction that occurred on Friday, October 7th. The stock was purchased at an average price of $7.50 per share, for a total transaction of $99,997.50. Following the completion of the acquisition, the director now owns 13,333 shares in the company, valued at $99,997.50. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP John P. Engels acquired 4,000 shares of the firm’s stock in a transaction that occurred on Friday, October 7th. The shares were purchased at an average price of $7.50 per share, with a total value of $30,000.00. Following the acquisition, the vice president now owns 98,425 shares of the company’s stock, valued at approximately $738,187.50. The disclosure for this purchase can be found here. Insiders own 9.33% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Nationwide Fund Advisors purchased a new position in shares of AxoGen during the second quarter worth about $105,000. Prudential Financial Inc. purchased a new position in shares of AxoGen during the third quarter worth about $109,000. TFS Capital LLC purchased a new position in shares of AxoGen during the second quarter worth about $113,000. BlackRock Advisors LLC boosted its position in shares of AxoGen by 57.4% in the third quarter. BlackRock Advisors LLC now owns 13,379 shares of the company’s stock worth $121,000 after buying an additional 4,878 shares in the last quarter. Finally, Rhumbline Advisers purchased a new position in shares of AxoGen during the second quarter worth about $132,000. Hedge funds and other institutional investors own 53.00% of the company’s stock.

5 Day Chart for NASDAQ:AXGN

Receive News & Stock Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related stocks with our FREE daily email newsletter.